Aberdare Ventures was founded in 1999 by partner Paul Klingenstein. Based in San Francisco, California, Aberdare Ventures has over $400 million of capital committed to the healthcare technology industry with emphases on medical device and biopharmaceutical product companies. J. Robert Scott was retained to recruit an investment professional to enrich and supplement the firm’s core senior team. The search resulted in the placement of two investment professionals – Sami Hamadi and Darren Hite. For more information, please contact lifesciences@j-robert-scott.com.

American Tower is a publicly traded industry leader in the wireless infrastructure market. They are one of the largest owners and operators of cellular towers and rooftop sites in North America and have international operations in Latin America and India. J. Robert Scott was retained to recruit a Chief Information Officer to connect IT more closely with the operations of the business in a way where it becomes a strategic leverage point for the corporation. For more information, please contact technology@j-robert-scott.com.

BiPar Sciences, Inc. is a biopharmaceutical company focused on the development of novel oncological therapeutics. Founded in 2002, BiPar Sciences Inc. raised over $53 million in funding with major investors including: Domain Associates, Vulcan Capital, Canaan Partners, PolyTechnos Venture-Partners, Asset Management Company, Quantum Technology Partners, and Lighthouse Capital Partners. The objective of our search was to recruit a Chief Executive Officer to lead the company to commercialization. The search resulted in the placement of Hoyoung Huh. Subsequent to the placement, the company was sold to Sanofi-Aventis in 2009 for over $500 million. For more information, please contact lifesciences@j-robert-scott.com.

COLT Group is a publicly traded telecommunications company providing services to major city-based customers throughout Europe, specializing in providing data, voice and managed services to major businesses, SMEs and wholesale customers. J. Robert Scott was retained to recruit a Chief Executive Officer of its new Data Center Services business. For more information, please contact technology@j-robert-scott.com.

Established in 1992, the Clinical Trials Office is the main administrative arm of clinical research for the Columbia University Medical Center at New York Presbyterian Hospital. Since its inception, the CTO has negotiated over 1,600 contracts representing over 500 sponsors.

Fidelity Investments is an international provider of financial services and investment resources that help individuals and institutions meet their financial objectives. In addition to more than 300 Fidelity mutual funds, the company also offer discount brokerage services, retirement services, estate planning, wealth management, securities execution and clearance, and life insurance.

Fidelity offers investment management, retirement planning, brokerage, and human resources and benefits outsourcing services to 24 million individuals and institutions as well as through 5,500 financial intermediary firms. The firm is the largest mutual fund company in the United States, the No. 1 provider of workplace retirement savings plans, the largest mutual fund supermarket and a leading online brokerage firm.

Founded in 1996, the International AIDS Vaccine Initiative (IAVI) is a global not-for-profit, public-private partnership that aims to prevent HIV infection through the research and development of HIV vaccine candidates. In addition to its scientific research and development efforts, IAVI conducts HIV/AIDS policy analyses and acts as an international advocate for the advancement of HIV prevention through vaccine development. The focus of the search was to recruit a highly relationship-oriented individual to precipitate growth and discipline within the organization. The search resulted in the placement of John McGoldrick. For more information, please contact lifesciences@j-robert-scott.com.

MicroCHIPS, Inc., based in Bedford, Massachusetts, is a biotechnology company that develops implantable drug delivery and biochemical sensing systems. MicroCHIPS was founded in 1999 by Dr. John Santini, Professors Michael Cima and Robert Langer of the Massachusetts Institute of Technology, and Terry McGuire of Polaris Venture Partners. The company has since attracted over $56 million in capital from leading venture and corporate investors with its promising implantable glucose-sensing platform. J. Robert Scott was retained to recruit a Vice President of Research and Development to create new applications for the MicroCHIPS platform technology and complementary technologies. The process resulted in the hiring of Robert Farra. For more information, please contact lifesciences@j-robert-scott.com.

The mission of the Massachusetts Institute of Technology Media Lab is to foster the invention of new technologies and concepts for Human Augmentation, with an emphasis on learning and cognition, arts and expression, affect and health, and social and economic development. The Media Lab serves as a unique bridge between inventors, academics, and the larger society, providing opportunities for theoretical prototypes to have a profound and pragmatic influence on society.

Pyramis Global Advisors is an investment management firm focused on serving institutional investors including corporate and public retirement funds, endowments, foundations, and other institutions, as well as non-U.S. investors. Pyramis offers active and risk-controlled domestic equity, international equity, fixed-income, high yield, real estate, and alternative strategies including equity market neutral and 130/30 disciplines.

QD Vision is a nanotechnology product company delivering a new generation of display and lighting solutions to major industries where color, power and design matter. Their investors include Highland Capital, In-Q-Tel, North Bridge Venture Partners, Open Innovation Ventures and DOE. J. Robert Scott was retained to recruit a Senior Vice President of Technology, a Vice President of Business Development and a Chief Executive Officer at the different stages of the company’s progression. For more information, please contact technology@j-robert-scott.com.

The Scottsdale Cultural Council is the non-profit organization that shapes and enhances the arts and cultural affairs of the City of Scottsdale. The Council manages the Scottsdale Center for the Performing Arts, the Scottsdale Museum of Contemporary Art, and the Scottsdale Public Art Program under a master agreement with the City.

Sun Catalytix is an early-stage renewable energy startup founded on groundbreaking science from the research lab of Professor Daniel Nocera at MIT, who developed a unique catalyst in the electrolysis process to turn solar energy into hydrogen. Their investors include Polaris Venture Partners, Tata Capital and DOE. J. Robert Scott was retained to recruit a Chief Executive Officer to lead the company through its next phase of evolution. For more information, please contact technology@j-robert-scott.com.

The Ford School of Public Policy is known to offer outstanding education for leadership in public policy analysis and public management and to excel in social science research that illuminates public policy issues and promotes better public policy. The program was founded in 1914 as the Institute of Public Administration and renamed the Ford School in 1999. Undergraduate, master’s and doctoral studies programs are all offered.

Venrock is a premier venture capital firm with offices in Palo Alto, New York, Cambridge, MA, and Israel. Originally established as the venture capital arm of the Rockefeller family, Venrock continues a seven-decade tradition of partnering with entrepreneurs to establish successful, enduring companies. Having invested $2.2 billion in 417 companies resulting in 124 IPOs and 117 M&A exits over the past 39 years, Venrock's investment returns place it among the top tier venture capital firms that have achieved consistently superior performance. With a primary focus on technology, healthcare, and energy, portfolio companies have included Apple Computer, Centocor, Check Point Software, DoubleClick, Gilead Sciences, Idec Pharmaceuticals, Illumina, Intel, Millennium Pharmaceuticals, Sirna Therapeutics, and StrataCom.

XTRAC is a proprietary workflow management software business that has been developed and customized for client use. J. Robert Scott was retained to recruit a CFO, a Senior Vice President of Strategy and Alliances and a Senior Vice President of Product Development and Support at the different stages of the company’s progression. For more information, please contact technology@j-robert-scott.com.

ZymoGenetics was founded in 1981 by three professors: Earl Davie and Benjamin Hall from the University of Washington and the late Michael Smith, 1993 Nobel Laureate in Chemistry and Professor of Biochemistry at the University of British Columbia. The company was focused on the discovery, development and commercialization of therapeutic proteins. ZymoGenetics completed an initial public offering in 2002 and in 2010, was acquired by Bristol-Myers Squibb. The focus of the search was to recruit a Chief Medical Officer who was capable of advancing the organization’s compounds into the clinic. The effort resulted in the placement of Nicole Onetto, MD. For more information, please contact lifesciences@j-robert-scott.com.